Welcome to the Investors section of the Combat Medical website. Here you will find the latest information relating to our products, which will include product updates, trial updates and news.

Latest News

Combat Medical shortlisted in The Telegraph Trade Awards 2018-Best New Entrant into International Markets 2018

        Combat Medical is proud to announce their inclusion in the 2018

More

Latest from @CombatCancer on Twitter

More

#BLADDR18 #HIVEC #ChemoHyperthermia #POSTER2

Come and see the posters @ #BLADDR18 #HIVEC #ChemoHyperthermia pic.twitter.com/9dX4Oee99G — Combat Medical #HIVEC #HIPEC

More

#BLADDR18 #HIVEC #POSTER1

There are some great posters @ #BLADDR18 #HIVEC pic.twitter.com/bDnahheB4s — Combat Medical #HIVEC #HIPEC (@CombatCancer)

More

Combat Medical #HIVEC #HIPEC @CombatCancer

Come and chat to us @ #BLADDR18 #HIVEC #ChemoHyperthermia pic.twitter.com/la8FErPaYo — Combat Medical #HIVEC #HIPEC

More

Combat sponsoring 3rd Global Congress on Bladder Cancer Madrid

Combat is proud to be sponsoring the Global Congress on Bladder Cancer on the 20th

More

The Scaleup Programme: supporting 30 companies for rapid growth | EEN

Combat Medical Ltd is proud to have been selected for The Scaleup Programme: supporting 30

More

COMBAT are exhibiting at BAUS 2018- 25th-27th Liverpool at the ACC. Stand 510

COMBAT are exhibiting at BAUS 2018- 25th-27th Liverpool at the ACC. Stand 510 Abstracts being

More

AUA2018 MAY 18-21 San Francisco: Stand 5358

Over 200 HIVEC patients RWD being presented in 2 clinical abstracts at AUA -Retrospective analysis

More

AUA18 – Mon 21st May 2018, 9:30-11:30, MCC West 3005

MP83-09_Chemohyperthermia with Mitomycin C and COMBAT System a new alternative to BCG in high risk

More